STAT+: Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug
A former Eli Lilly sales rep filed a lawsuit alleging that she was fired after complaining the company was promoting its Mounjaro diabetes drug to combat weight loss before receiving regulatory approval to do so.
Key points
- A physician may prescribe a medicine for an unapproved use, but a drugmaker is not permitted to market its drug for that purpose.
- The phrase refers to promoting a medicine for a usage that was not approved by the Food and Drug Administration.
- Such promotions are known as off-label marketing in the pharmaceutical industry.
Jennifer Mansion, who was hired as a senior territory manager in Dallas four years ago, claimed that she observed other Lilly sales reps promoting the diabetes drug as a salve for obesity.
Additional details
- Continue to STAT+ to read the full story….
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →
Advertisement
Every article behind this summary — 1 article from 1 outlet
Get stories like this in your inbox.
Subscribe — it's freeOne free email at 6am — your topics, deduplicated, five minutes. No account, no paywall.